243 related articles for article (PubMed ID: 18356147)
21. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
[TBL] [Abstract][Full Text] [Related]
22. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
[TBL] [Abstract][Full Text] [Related]
23. Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors.
Klopocki E; Kristiansen G; Wild PJ; Klaman I; Castanos-Velez E; Singer G; Stöhr R; Simon R; Sauter G; Leibiger H; Essers L; Weber B; Hermann K; Rosenthal A; Hartmann A; Dahl E
Int J Oncol; 2004 Sep; 25(3):641-9. PubMed ID: 15289865
[TBL] [Abstract][Full Text] [Related]
24. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
25. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer.
Kinoshita T; Nomoto S; Kodera Y; Koike M; Fujiwara M; Nakao A
Hepatogastroenterology; 2011; 58(107-108):1051-6. PubMed ID: 21830441
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway.
Su HY; Lai HC; Lin YW; Liu CY; Chen CK; Chou YC; Lin SP; Lin WC; Lee HY; Yu MH
Int J Cancer; 2010 Aug; 127(3):555-67. PubMed ID: 19957335
[TBL] [Abstract][Full Text] [Related]
28. ST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2.
Jandrig B; Seitz S; Hinzmann B; Arnold W; Micheel B; Koelble K; Siebert R; Schwartz A; Ruecker K; Schlag PM; Scherneck S; Rosenthal A
Oncogene; 2004 Dec; 23(57):9295-302. PubMed ID: 15489893
[TBL] [Abstract][Full Text] [Related]
29. EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.
Giannini G; Ambrosini MI; Di Marcotullio L; Cerignoli F; Zani M; MacKay AR; Screpanti I; Frati L; Gulino A
Mol Carcinog; 2003 Dec; 38(4):188-200. PubMed ID: 14639658
[TBL] [Abstract][Full Text] [Related]
30. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
Nimmrich I; Sieuwerts AM; Meijer-van Gelder ME; Schwope I; Bolt-de Vries J; Harbeck N; Koenig T; Hartmann O; Kluth A; Dietrich D; Magdolen V; Portengen H; Look MP; Klijn JG; Lesche R; Schmitt M; Maier S; Foekens JA; Martens JW
Breast Cancer Res Treat; 2008 Oct; 111(3):429-37. PubMed ID: 17965955
[TBL] [Abstract][Full Text] [Related]
31. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
[TBL] [Abstract][Full Text] [Related]
32. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome.
Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY
Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371
[TBL] [Abstract][Full Text] [Related]
33. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer.
Cheng YY; Yu J; Wong YP; Man EP; To KF; Jin VX; Li J; Tao Q; Sung JJ; Chan FK; Leung WK
Br J Cancer; 2007 Oct; 97(7):895-901. PubMed ID: 17848950
[TBL] [Abstract][Full Text] [Related]
34. Silencing of secreted frizzled-related protein genes in MSI colorectal carcinogenesis.
Tanaka J; Watanabe T; Kanazawa T; Tada T; Kazama Y; Tanaka T; Nagawa H
Hepatogastroenterology; 2008; 55(85):1265-8. PubMed ID: 18795670
[TBL] [Abstract][Full Text] [Related]
35. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
Wang Y; Li J; Cui Y; Li T; Ng KM; Geng H; Li H; Shu XS; Li H; Liu W; Luo B; Zhang Q; Mok TS; Zheng W; Qiu X; Srivastava G; Yu J; Sung JJ; Chan AT; Ma D; Tao Q; Han W
Cancer Res; 2009 Jun; 69(12):5194-201. PubMed ID: 19509237
[TBL] [Abstract][Full Text] [Related]
36. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue.
Yan PS; Venkataramu C; Ibrahim A; Liu JC; Shen RZ; Diaz NM; Centeno B; Weber F; Leu YW; Shapiro CL; Eng C; Yeatman TJ; Huang TH
Clin Cancer Res; 2006 Nov; 12(22):6626-36. PubMed ID: 17121881
[TBL] [Abstract][Full Text] [Related]
37. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
Yu J; Tao Q; Cheng YY; Lee KY; Ng SS; Cheung KF; Tian L; Rha SY; Neumann U; Röcken C; Ebert MP; Chan FK; Sung JJ
Cancer; 2009 Jan; 115(1):49-60. PubMed ID: 19051296
[TBL] [Abstract][Full Text] [Related]
38. Expression of the WASP verprolin-homologues (WAVE members) in human breast cancer.
Fernando HS; Davies SR; Chhabra A; Watkins G; Douglas-Jones A; Kynaston H; Mansel RE; Jiang WG
Oncology; 2007; 73(5-6):376-83. PubMed ID: 18509249
[TBL] [Abstract][Full Text] [Related]
39. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer.
de Maat MF; van de Velde CJ; Umetani N; de Heer P; Putter H; van Hoesel AQ; Meijer GA; van Grieken NC; Kuppen PJ; Bilchik AJ; Tollenaar RA; Hoon DS
J Clin Oncol; 2007 Nov; 25(31):4887-94. PubMed ID: 17971584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
